Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline.

Tonelli M, Wanner C; Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members.

Ann Intern Med. 2014 Feb 4;160(3):182. doi: 10.7326/M13-2453.

PMID:
24323134
2.

Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.

Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members.

Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.

PMID:
23732715
3.

KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.

Sarnak MJ, Bloom R, Muntner P, Rahman M, Saland JM, Wilson PW, Fried L.

Am J Kidney Dis. 2015 Mar;65(3):354-66. doi: 10.1053/j.ajkd.2014.10.005. Epub 2014 Nov 18. Review.

PMID:
25465166
4.

KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient.

Wanner C, Tonelli M; Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members.

Kidney Int. 2014 Jun;85(6):1303-9. doi: 10.1038/ki.2014.31. Epub 2014 Feb 19. Review.

PMID:
24552851
5.

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative.

Kasiske B, Cosio FG, Beto J, Bolton K, Chavers BM, Grimm R Jr, Levin A, Masri B, Parekh R, Wanner C, Wheeler DC, Wilson PW; National Kidney Foundation.

Am J Transplant. 2004;4 Suppl 7:13-53.

6.

[Clinical practice guidelines for the management of dyslipidemia in chronic kidney disease].

Shoji T.

Nihon Jinzo Gakkai Shi. 2013;55(7):1267-75. Review. Japanese. No abstract available.

PMID:
24288962
7.

KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.

Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI.

Am J Kidney Dis. 2014 May;63(5):713-35. doi: 10.1053/j.ajkd.2014.01.416. Epub 2014 Mar 16. Review.

PMID:
24647050
8.

Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: rationale and design of the ASsessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial.

Ueshima K, Kasahara M, Koya D, Babazono T, Sato T, Imamoto M, Yasuno S, Fujimoto A, Tanaka S, Kimura G, Nakao K.

Clin Exp Nephrol. 2013 Apr;17(2):211-7. doi: 10.1007/s10157-012-0676-5. Epub 2012 Sep 6.

PMID:
22948416
9.

Is lipid management effective for all stages of CKD?.

Ku E, Campese V.

Blood Purif. 2013;35(1-3):26-30. doi: 10.1159/000345932. Epub 2013 Jan 22. Review.

10.

Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.

Rysz J, Gluba-Brzózka A, Banach M, Więcek A.

Int Urol Nephrol. 2015 May;47(5):805-13. doi: 10.1007/s11255-015-0937-9. Epub 2015 Mar 11. Review.

PMID:
25758011
11.

Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD.

Ruzicka M, Quinn RR, McFarlane P, Hemmelgarn B, Ramesh Prasad GV, Feber J, Nesrallah G, MacKinnon M, Tangri N, McCormick B, Tobe S, Blydt-Hansen TD, Hiremath S.

Am J Kidney Dis. 2014 Jun;63(6):869-87. doi: 10.1053/j.ajkd.2014.03.003. Epub 2014 Apr 12.

PMID:
24725980
12.

Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD.

Markossian T, Burge N, Ling B, Schneider J, Pacold I, Bansal V, Leehey D, Stroupe K, Chang A, Kramer H.

Am J Kidney Dis. 2016 Jun;67(6):965-77. doi: 10.1053/j.ajkd.2015.12.030. Epub 2016 Mar 2.

PMID:
26943983
13.

Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.

Ahmed MH, Khalil AA.

Saudi J Kidney Dis Transpl. 2010 Nov;21(6):1021-9. Review.

14.

Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians.

Qaseem A, Hopkins RH Jr, Sweet DE, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians.

Ann Intern Med. 2013 Dec 17;159(12):835-47.

PMID:
24145991
15.

Potential benefit of statin therapy for dyslipidemia with chronic kidney disease: Fluvastatin Renal Evaluation Trial (FRET).

Inoue T, Ikeda H, Nakamura T, Abe S, Taguchi I, Kikuchi M, Toyoda S, Miyazono M, Kishi T, Sanai T, Node K.

Intern Med. 2011;50(12):1273-8. Epub 2011 Jun 15.

16.

Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.

Hou W, Lv J, Perkovic V, Yang L, Zhao N, Jardine MJ, Cass A, Zhang H, Wang H.

Eur Heart J. 2013 Jun;34(24):1807-17. doi: 10.1093/eurheartj/eht065. Epub 2013 Mar 6. Review.

PMID:
23470492
17.

Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.

Koren MJ, Davidson MH, Wilson DJ, Fayyad RS, Zuckerman A, Reed DP; ALLIANCE Investigators.

Am J Kidney Dis. 2009 May;53(5):741-50. doi: 10.1053/j.ajkd.2008.11.025. Epub 2009 Feb 11.

PMID:
19216014
18.

[Dyslipidemia and the risk of kidney disease].

Ligabue G, Cavazzini F, Albertazzi A.

G Ital Nefrol. 2007 Sep-Oct;24 Suppl 38:8-12. Italian.

PMID:
17922441
19.

Assessment of nonimmunologic factors in kidney transplant recipients according to Kidney Disease Improving Global Outcomes.

Dounousi E, Mitsis M, Spanos G, Pappas C, Koutlas V, Tzalavra I, Xarisis C, Glantzounis G, Fatouros M, Siamopoulos KC.

Transplant Proc. 2012 Nov;44(9):2709-11. doi: 10.1016/j.transproceed.2012.09.010.

PMID:
23146500
20.

[Effect of statins on renal function].

Kasahara M.

Nihon Jinzo Gakkai Shi. 2013;55(7):1295-300. Review. Japanese. No abstract available.

PMID:
24288966

Supplemental Content

Support Center